WHITEHAWK THERAPEUTICS, INC. Current Assets
WHITEHAWK THERAPEUTICS, INC. (WHWK) had Current Assets of $192.41 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-06
- 2026-06-30: Assets, Current $192.41M.
- 2026-03-31: Assets, Current $125.55M.
- 2025-12-31: Assets, Current $149.01M.
- 2025-09-30: Assets, Current $165.04M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $192.41M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $125.55M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $149.01M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $165.04M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $178.67M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $232.61M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $61.29M 10-K · filed 2026-03-12 | |
| 2024-09-30 | $77.31M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $93.00M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $102.57M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $124.59M 10-K · filed 2025-03-28 | |
| 2023-09-30 | $132.88M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $144.92M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $164.93M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $180.03M 10-K · filed 2024-03-13 | |
| 2022-09-30 | $189.86M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $124.33M 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $135.62M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $151.27M 10-K · filed 2023-03-29 | |
| 2021-09-30 | $162.02M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $37.39M 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $41.00M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $18.68M 10-K · filed 2022-03-17 | $44.72M 10-K · filed 2021-03-11 |
| 2020-09-30 | $49.58M 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $45.43M 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $35.39M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $39.57M 10-K · filed 2021-03-11 | |
| 2019-09-30 | $44.80M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $48.79M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $54.30M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $63.98M 10-K · filed 2020-03-16 | |
| 2018-09-30 | $70.04M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $69.43M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $14.61M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $20.90M 10-K · filed 2019-03-07 | |
| 2017-09-30 | $25.86M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $29.64M 10-Q · filed 2017-08-10 | |
| 2017-03-31 | $36.12M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $2.23M 10-K · filed 2018-03-15 | |
| 2013-03-31 | $3.83K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $8.11K 10-Q · filed 2013-05-15 | |
| 2012-09-30 | $11.27K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $15.56K 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $24.22K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $6.63K 10-K · filed 2013-03-28 | |
| 2011-09-30 | $10.51K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $15.48K 10-Q · filed 2011-08-15 | |
| 2010-12-31 | $29.40K 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |